Glycomet Trio 1 Forte

Composition

Glimepiride 2 mg + Metformin hydrochloride (sustained release) 1000 mg + Voglibose 0.3 mg tablets

Uses of Glycomet Trio 1 Forte

Type 2 diabetes mellitus in adults when diet and exercise alone or dual therapy is inadequate; helps control post-meal and fasting blood glucose

• •Lowers fasting blood glucose
• •Reduces post-meal sugar spikes
• •Improves overall glycaemic control (HbA1c)
• •Supports insulin action and reduces insulin resistance
• •Helps achieve better control with triple therapy in one tablet

How it works

Metformin reduces glucose production in the liver and improves insulin sensitivity. Glimepiride increases insulin release from the pancreas. Voglibose slows carbohydrate absorption from the intestine by inhibiting alpha-glucosidase, reducing post-meal glucose spikes.

Directions for use

Oral tablet; take exactly as prescribed, usually once daily with/after the main meal (often dinner) to reduce stomach upset and hypoglycaemia risk. Swallow whole; do not crush or chew (SR component).

Side effects

Common side effects of Glycomet Trio 1 Forte may include:

• •Hypoglycaemia
• •nausea
• •diarrhoea
• •abdominal pain